We observed a reduction in indicators of PsA activity with PsAID‐12 reduced at week‐10 (median reduction −6.1%) and week‐20 (median reduction −56.1%), and RAPID3 reduced at week‐10 (median reduction −36.4%) and week‐20 (median reduction −63.6%), although this did not reach statistical significance (Table 2 ). 3.2.
← all excerpts
Increased physical activity promotes skin clearance, improves cardiovascular and psychological health, and increases functional capacity in patients with psoriasis.
1
—
—